Bidders Line Up for Teva’s Women Health Unit, Report Says
Church & Dwight Co. and Cooper Companies Inc. join other bidders for troubled drugmaker assets, Bloomberg reported Tuesday
Earlier this month, Israel-based Teva, one of the world’s largest generic drugmakers, announced its intentions to sell some of its assets to the count of $2 billion
The announcement came after the company published quarterly reports that sent the company's stock price down to a 14-years low, cementing Teva's troubles over its $36.8 billion debt.Citing people familiar with the matter, Bloomberg reported Teva may sell the unit as a whole or split the U.S. and European operations after bidders showed interest in the separate entities. According to Bloomberg, other potential bidders for Teva's women’s health unit include India-based Intas Pharmaceuticals Ltd., French buyout firm Astorg Partners, Pierre Fabre SA, CVC Capital Partners and Apollo Global Management LLC.